medibles | CBD Personalized

May 2022

You’re unique. Your CBD regimen should be too.

medibles™ Expands Proprietary Algorithm and Questionnaire Tailored to Each Unique Customer

Today, Los Angeles, May 13, 2022 /PRNewswire/ — medibles, the leading next-generation subscription-based platform, announced it had enhanced its proprietary algorithm and online health questionnaire. medibles’ algorithm is based on thousands of research studies and the expertise of the company’s Medical Advisory Board. As a result, the individualized assessments meet consumers’ desires to find the correct CBD dosage […]

medibles™ Expands Proprietary Algorithm and Questionnaire Tailored to Each Unique Customer Read More »

medibles™ Expands its CBD-Drug Interaction Database, Cross-Examining More Than 5,400 Prescription Medications

Certain drugs interact with Cannabidiol; these interactions typically involve drugs metabolized by CYP450 enzymes and could possibly interact with CBD. LOS ANGELES, MAY 11, 2022 /PRNewswire/ — medibles™, medibles, the leading next-generation subscription-based platform, today announced further expansion of its CBD-Drug Interaction (CBDDI) database to deliver a truly personalized approach to taking CBD oil for health

medibles™ Expands its CBD-Drug Interaction Database, Cross-Examining More Than 5,400 Prescription Medications Read More »